| Display title | Chemistry:CSP-2503 |
| Default sort key | CSP-2503 |
| Page length (in bytes) | 3,589 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 805789 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Importwiki |
| Date of page creation | 21:23, 5 February 2024 |
| Latest editor | imported>Importwiki |
| Date of latest edit | 21:23, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | CSP-2503 is a potent and selective 5-HT1A receptor agonist, 5-HT2A receptor antagonist, and 5-HT3 receptor antagonist of the naphthylpiperazine class. First synthesized in 2003, it was designed based on computational models and QSAR studies. In rat studies, CSP-2503 has demonstrated [[anxiolytic effects... |
